%PDF-1.7 % 8 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20150630232037+03'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 9 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /PZ 1 >> endobj 9 0 obj <> stream xMS0=˶qSFɍ dQ-#Mïl bj%2xhGwweÉ skL?O%|[w4?_@?s+7)4r[38,PIzYšnէ%sRm(THTY IVq(}/7A'^8FttNHRBrN⢆FIh&'S2索% CU%Mە o)8P ((> /PZ 1 >> endobj 11 0 obj <> stream xMs0=$[\;v&29[rdB}%[4wWhHHX+7#4Dmq|E0mtC>% ;FeӨ]Zhji4&dtq LSyLYID l,a.-L@׃K<뿅 [LqS{>b&rdVb=lD- eu}VnXQyb\KZ"-X~Q5/GHtb!*Fx%`r *YkpD֍ lqH'9l!])QfP)L YVaF3^+#R#4+|-$YQHm;NsʸbkxkQ>ò9rE]gUʹM-hc:QA'a[HfP/K>i6#7QZ ֮ tG_GAV˙؛_GX͏p!r)"D %.r@bKso/nXH-+hؒg ,-GP?n)<mK`Fqy[FyxѷqƎmN}roiwOcmS<3%o v|5)ǻt ho>5 N2:;cH{ݞ-\?{ endstream endobj 12 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20150630232037+03'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 13 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /PZ 1 >> endobj 13 0 obj <> stream xAo m:i[ܪM64>&GKMC0?{AY"` .+\PQ.ޯ#Wwa@ȟ~z9m$A`8 3XpmvyNHtX]WmB-t@3łbWCˤV +U>JR+xmS~ڵPv :V9{jK^e5RQPNhᄇpy ՔVIAk0|DE2 Q O`KJ@ ;i$]x%J B9plsB-xii9S)Y;pXmG6E)RZB{"krVcRN{Nk/!Y'!$w*z N>5 ELz1Gur>Huqqhȋ`K;/I#YRbVr󝗘"q3AjЄ"BuwBU9^<%I}5p*֐2rF՘E(h> /PZ 1 >> endobj 15 0 obj <> stream xMo0|F$u6nܪoIڦo?;1/+.t:%8~?1Io[h}W 8XOe2Bϛ~]#K04y%8΂ DdqL W)hyЬKA)P\;]'8ZVp%ϡ7v"8u]JS! RABa!N kf8*AO kF j " 9@hW6-Yo,\4j Ox575rImؼ $1籹++:^ʷ5C|)(Y8T3 JVuQOc+Te%rA%>.nR+gRP=DDQh1J't<"|\FU6Dos8Lj'sB#޹52);O8+ߞ&Ӈۻ:w]!+V=U9S Ax"NBv%߉;ꌝdC۪-*RybƉS+/hyN+o VMMӐ3=U{{Ϫ}*OTB>l׽dLKVq~+y8ҔxWFKj a:&id3[>x=e4Ev"`߈ۖ^ߐ endstream endobj 16 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20150630232037+03'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 17 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /PZ 1 >> endobj 17 0 obj <> stream xMs0{lu$@|\;v&erP@Z 캿d:i;Y_~}W9.nWhbyIgp>,f,aAO%> /Annots [ 5 0 R ] /PZ 1 >> endobj 19 0 obj <> stream xn0y9Ȥ$jH !J߾Don\&a3i#H6X[%dMYH>a WnWulsx~ҍS[mMBB;k!c弌ix QP hyu/qA{mHxMgQвKhv5*Qi. `߶|wY:pp葩yQo?uٮ֌+[ECSEgF99;rI ^"%)/|+ L….{_V)ˡyd 95;>!ucεB)FtrӦ5@Uzr"e˰. -<> /PZ 1 >> endobj 21 0 obj <> stream xˎ0ifLm㞹3Qi4`aUs(iT/&x⬙K?qA+BjVM#(q~gl_mgu{kNfm݇Br]s_  (9$/xlaú pߛFE^B"RAZ^1ɽNMёR\U5S&bysѓ0O̓f6ΏKCkjOMHXJ5qT{awEͬuT3ʿ; Ks}qT^dEfRz%\*m 6BET~[NPti>M؁G~f_ ҽRnjNp'go7t Ӏ!Jm_o}"J<. &?jv{ endstream endobj 22 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20150630232037+03'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 23 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /PZ 1 >> endobj 23 0 obj <> stream xo0Fm'u6nܪM8Ccic2lB5Kt @p~]UsQ>N3L4/9MfO44Fnn#}vGKq0 qFI`UΖ1+SV\|kni 8_PPr҂i@-bu\szQL {Vj&O3Ŏ`%H٢ ^ /!޽TL^!١O]Vy%Ϙhbi7Ϙ=/QEv8Q1mKR饁ˠwyn)!Ґ6zh.>b upW*%xnh;dcj-JPBNIB]LTh[Zp Ǻ\0{?6.h_hei@+~)-R<*$1Eۧz;Sh19מee x@bmOOԱzПv#獶7Cf@xLœmo ߎp0Y,q1^P᪽t]o]Q endstream endobj 24 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20150630232037+03'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 25 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /PZ 1 >> endobj 25 0 obj <> stream xn0~9:$jh ַ %R}I^Rrꤩa3FhN~;us|M(fp6%|Y/w/9YRo#w}+%<΂ Ddq,rP1`uydU %!Pw6&x)Hɵ\/Yͳ(t$u)$vc-`lP@G6N#]!i "KNXa"Sd[!)j $/ZڲG/X5\drZ>4(\KH  4R<אBFR0($C>{rgBx$#`9 V|ЄcWL!3{P`j(scC+yϰV#&{8u/D_jͿ8d[u4RQ7[! -Y065TK KqalȞN,D򰸥Jҵ'Y^OXiscQZƣq%1 咳JM||:phJ+n??8c9fly;s(Mv5x[ØsOkm1L Ϳx lޝ endstream endobj 26 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20150630232037+03'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 27 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /PZ 1 >> endobj 27 0 obj <> stream xMo0q;,N&-8ēԆV34.([~?ow~*Ѧy~#%}ƀOz%)K[mtQcX$dqF9, |' 0)VLЬiִЪF0*(ٵBP*UJi`y/~1<_/tءtF.#y]7BMd'iP eh7l U:zP$~EbMk:P0!u9N>Ӷu##ILT%0$tĆ]jAb S0y}6p[},T4PLsZjI } F҇dmcFg\l0R0̌xVc;?:a~qlaH$$QJԝOWP@0Ψ?Ơh5-\? endstream endobj 28 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20150630232037+03'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 29 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 6 0 R 7 0 R ] /PZ 1 >> endobj 29 0 obj <> stream xMs0{L!cԝ)i%9( cD.u}%14ь ѻ}[(+mUiUH{"8 @ KԳ_.2a67֏]uT zH=ZJ=bC'D.= =wB=9 Oc&@*!9I) r>`=DW͛9Ow۪Ƌ;:l$lD \L1<&j߂&3I&T%&`jL)ԀdxBf,~N#"juDt5R'2ESAD> /H /I>> endobj 6 0 obj <> /H /I>> endobj 7 0 obj <> /H /I>> endobj 30 0 obj << /Title (Clindamycin Phosphate Topical Lotion For Acne - Clindamycin 300mg Cap Ranbaxy Uses) /Subject (Clindamycin oral medication for acne, clindamycin 300mg cap ranbaxy, uses for clindamycin phosphate topical gel 1, clindamycin 150 mg, clindamycin phosphate for acne scars, clindamycin phosphate topical solution for acne, clindamycin for bv reviews) /Keywords (fougera clindamycin phosphate gel price, clindamycin phosphate gel usp 1, clindamycin 300 mg capsule uses, clindamycin for dogs, clindamycin phosphate topical lotion for acne scars, clindamycin hcl 150 mg capsules, clindamycin for mrsa in dogs, clindamycin oral dose for cellulitis, clindamycin phosphate gel usp price, generic name for clindamycin topical) /Producer (TCPDF 6.2.6 \(http://www.tcpdf.org\)) /CreationDate (D:20150630232037+03'00') /ModDate (D:20150630232037+03'00') /Trapped /False >> endobj 31 0 obj << /Type /Metadata /Subtype /XML /Length 5265 >> stream application/pdf Clindamycin Phosphate Topical Lotion For Acne - Clindamycin 300mg Cap Ranbaxy Uses Clindamycin oral medication for acne, clindamycin 300mg cap ranbaxy, uses for clindamycin phosphate topical gel 1, clindamycin 150 mg, clindamycin phosphate for acne scars, clindamycin phosphate topical solution for acne, clindamycin for bv reviews fougera clindamycin phosphate gel price, clindamycin phosphate gel usp 1, clindamycin 300 mg capsule uses, clindamycin for dogs, clindamycin phosphate topical lotion for acne scars, clindamycin hcl 150 mg capsules, clindamycin for mrsa in dogs, clindamycin oral dose for cellulitis, clindamycin phosphate gel usp price, generic name for clindamycin topical 2015-06-30T23:20:37+03:00 2015-06-30T23:20:37+03:00 2015-06-30T23:20:37+03:00 fougera clindamycin phosphate gel price, clindamycin phosphate gel usp 1, clindamycin 300 mg capsule uses, clindamycin for dogs, clindamycin phosphate topical lotion for acne scars, clindamycin hcl 150 mg capsules, clindamycin for mrsa in dogs, clindamycin oral dose for cellulitis, clindamycin phosphate gel usp price, generic name for clindamycin topical TCPDF 6.2.6 (http://www.tcpdf.org) uuid:fe6459a1-6563-b8ee-be8e-70a4b125d7b3 uuid:fe6459a1-6563-b8ee-be8e-70a4b125d7b3 http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text endstream endobj 32 0 obj << /Type /Catalog /Version /1.7 /Pages 1 0 R /Names << >> /ViewerPreferences << /Direction /L2R >> /PageLayout /SinglePage /PageMode /UseNone /OpenAction [8 0 R /FitH null] /Metadata 31 0 R >> endobj xref 0 33 0000000000 65535 f 0000013590 00000 n 0000013937 00000 n 0000013720 00000 n 0000013826 00000 n 0000014051 00000 n 0000014491 00000 n 0000014865 00000 n 0000000015 00000 n 0000000465 00000 n 0000001292 00000 n 0000001744 00000 n 0000002536 00000 n 0000002988 00000 n 0000003739 00000 n 0000004191 00000 n 0000004981 00000 n 0000005433 00000 n 0000006188 00000 n 0000006658 00000 n 0000007444 00000 n 0000007896 00000 n 0000008664 00000 n 0000009116 00000 n 0000009891 00000 n 0000010343 00000 n 0000011126 00000 n 0000011578 00000 n 0000012374 00000 n 0000012850 00000 n 0000015137 00000 n 0000016748 00000 n 0000022096 00000 n trailer << /Size 33 /Root 32 0 R /Info 30 0 R /ID [ ] >> startxref 22305 %%EOF